ID
30803
Description
Study part: 12 Lead ECG- Follow-up. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Keywords
Versions (1)
- 6/20/18 6/20/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
June 20, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
12 Lead ECG- Follow-up Pazopanib Macular Degeneration MD1103367
Similar models
12 Lead ECG- Follow-up
- StudyEvent: ODM
C1522577 (UMLS CUI-3)
C4072785 (UMLS CUI [1,2])
C2911685 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
C2985739 (UMLS CUI-2)
C1518422 (UMLS CUI-3)
(Comment:en)
C2985739 (UMLS CUI-2)
(Comment:en)
(Comment:en)